by Josh Forsythe, on March 28, 2018
Life gets better when we enter our "golden years" and retire, doesn’t it? Not necessarily. Because we are living longer, we face the possibility of living with an age-related chronic …
Read Storyby Josh Forsythe, on March 26, 2018
The Moffitt Morsani Molecular Laboratory, located within the Moffitt Cancer Center, announced today that it has launched a new clinical NGS assay, Solid Tumor Actionable Result, or STAR. STAR is based …
Read Storyby Josh Forsythe, on March 26, 2018
PierianDx will be highlighting germline features of its genomics technology platform the American College of Medical Genetics and Genomics (ACMG) annual meeting April 10-14 in Charlotte, North Carolina. Representatives from …
Read Storyby Josh Forsythe, on March 23, 2018
When CMS initiated a national coverage analysis for NGS-based testing for advanced cancer on November 30, 2017, it stirred up a lot of debate among the leaders in precision medicine, …
Read Storyby Josh Forsythe, on March 19, 2018
We are excited to attend the upcoming Precision Oncology Experimental Therapeutics (POET) Congress in Calgary, Alberta the first week in April. We will have an opportunity to collaborate with precision …
Read Storyby Josh Forsythe, on March 16, 2018
On April 5 and 6 oncology leaders will convene in Calgary, Alberta to participate in the 2nd International Precision Oncology and Experimental Therapeutics (POET) Congress. The annual meeting supports the …
Read Storyby Josh Forsythe, on March 16, 2018
Genetic diseases are the leading cause of death for infants in North America, affecting an estimated 4 percent of newborns. In MIT Technology Review, Rady Children’s Hospital in San Diego …
Read Storyby Josh Forsythe, on March 16, 2018
Laura J. Tafe, MD, associate professor of pathology and laboratory medicine at Geisel School of Medicine at Dartmouth, and assistant director of the Laboratory for Clinical Genomics and Advanced Technologies, …
Read Storyby Josh Forsythe, on March 15, 2018
While healthcare continues to improve, advances in technologies and treatments have also made it more complex. It’s estimated that nearly 100,000 patients die every year due to medical errors [1] …
Read Storyby PierianDx, on March 14, 2018
by Brad Herrick, PierianDx Like most people who have been going to HIMSS for some time, both as an attendee and sponsor, I have been inspired by the hope of …
Read Storyby Josh Forsythe, on March 14, 2018
PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today a partnership with Cancer Genetics, Inc. (CGI) (Nasdaq: CGIX) to provide a …
Read Storyby Josh Forsythe, on March 8, 2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace …
Read Story
77 Maryland Plaza
St. Louis, Missouri 63108
314-628-0035